共 50 条
- [21] Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older Infectious Diseases and Therapy, 2023, 12 : 2367 - 2386
- [28] Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2014, 3 (01) : 33 - 42